CLINICAL TRIALS PROFILE FOR MEFOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER

All Clinical Trials for MEFOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00343317 ↗	Prophylactic Intrapartum Antibiotics and Immunological Markers for Postpartum Morbidity in HIV Positive Women	Completed	Bristol-Myers Squibb	N/A	2003-02-01	Postpartum infections are among the leading causes of maternal mortality world-wide, particularly in under-resourced countries. Available data suggests that HIV infected women are at greater risk of postpartum complications than uninfected women. In South Africa, HIV/AIDS and related infections are now cumulatively the leading causes of maternal deaths (though indirectly), with puerperal sepsis among the 5 most common causes. This was a prospective longitudinal cohort of HIV infected (n = 675) and uninfected (n = 648) women. These were women in whom vaginal delivery was anticipated, and were recruited at > 36 weeks of gestation during the antenatal period. Hypothesis - HIV infected women are at increased risk of postpartum infectious morbidity and this morbidity can be reduced by use of prophylactic intrapartum antibiotics.
NCT00343317 ↗	Prophylactic Intrapartum Antibiotics and Immunological Markers for Postpartum Morbidity in HIV Positive Women	Completed	University of KwaZulu	N/A	2003-02-01	Postpartum infections are among the leading causes of maternal mortality world-wide, particularly in under-resourced countries. Available data suggests that HIV infected women are at greater risk of postpartum complications than uninfected women. In South Africa, HIV/AIDS and related infections are now cumulatively the leading causes of maternal deaths (though indirectly), with puerperal sepsis among the 5 most common causes. This was a prospective longitudinal cohort of HIV infected (n = 675) and uninfected (n = 648) women. These were women in whom vaginal delivery was anticipated, and were recruited at > 36 weeks of gestation during the antenatal period. Hypothesis - HIV infected women are at increased risk of postpartum infectious morbidity and this morbidity can be reduced by use of prophylactic intrapartum antibiotics.

Clinical Trial Conditions for MEFOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER

Condition Name

Condition Name for MEFOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER
Intervention	Trials
Puerperal Sepsis	1

Condition MeSH

Condition MeSH for MEFOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER
Intervention	Trials
Sepsis	1
HIV Seropositivity	1

Clinical Trial Locations for MEFOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER

Trials by Country

Trials by Country for MEFOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER
Location	Trials
South Africa	1

Clinical Trial Progress for MEFOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER

Clinical Trial Phase

Clinical Trial Phase for MEFOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER
Clinical Trial Phase	Trials
N/A	1

Clinical Trial Status

Clinical Trial Status for MEFOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER
Clinical Trial Phase	Trials
Completed	1

Clinical Trial Sponsors for MEFOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER

Sponsor Name

Sponsor Name for MEFOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER
Sponsor	Trials
Bristol-Myers Squibb	1
University of KwaZulu	1

Sponsor Type

Sponsor Type for MEFOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER
Sponsor	Trials
Industry	1
Other	1